Pembrolizumab and EV With Radiation Therapy for MIBC Patients (PEVRAD)
Clinical trial NCT05879653 · RECRUITING
Trial details
- NCT number
- NCT05879653
- Sponsor
- Kyoto University Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-01
- Primary completion
- 2025-09-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.